RTTNews | Apr 15, 2021 09:54AM EDT

09:54 Thursday, April 15, 2021 (RTTNews.com) - Inovio Pharmaceuticals, Inc. (INO) shares are rising more than 15 percent on Thursday morning trade as the biotechnology company announced that its new study of DNA vaccine candidate for COVID-19, INO-4800 induced a robust T cell response against all spike protein variants tested.

The company said it believes that the results will be key in providing protection against SARS-CoV-2 variants. Inovio submitted the study for peer review.

Currently, shares are at $10.19, up 15.25 percent from the previous close of $8.84 on a volume of 20,862,869. The shares have traded in a range of $7.36-$33.79 on average volume of 14,520,545. The shares have been showing an upswing since Monday.

Read the original article on RTTNews ( https://www.rttnews.com/3185345/stock-alert-inovio-pharma-gains-15-on-positive-results-for-its-covid-vaccine-candidate.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved